Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- STLA -13.4% (lowers guidance)
Other news:
- ASTS -2.1% (Announces Preliminary Results of Redemption of Public Warrants)
- BHVN -2% (Initiates Pivotal Trial of Novel Investigational Drug for Treatment of Migraine)
- ALV -1.9% (retires repurchased shares, decreases number of issued shares)
- SERV -1.4% (files $200 mln mixed shelf securities offering)
- CSTL -1.3% (New Data at ASTRO 2024 Shows Castle Biosciences' DecisionDx-SCC Test Provides More Precise Risk Stratification Than BWH Staging Alone to Guide Intensified Treatment for Immune Suppressed Patients with High-Risk Cutaneous Squamous Cell Carcinoma)